Detalhe da pesquisa
1.
155R is a novel structural protein of bovine adenovirus type 3, but it is not essential for virus replication.
J Gen Virol
; 98(4): 749-753, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28086071
2.
Adenoviral E2 IVa2 protein interacts with L4 33K protein and E2 DNA-binding protein.
J Gen Virol
; 94(Pt 6): 1325-1334, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23388198
3.
EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
J Gene Med
; 14(2): 77-89, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22228563
4.
The 2000HIV study: Design, multi-omics methods and participant characteristics.
Front Immunol
; 13: 982746, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36605197
5.
Vaccine approaches conferring cross-protection against influenza viruses.
Expert Rev Vaccines
; 16(11): 1141-1154, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28925296
6.
Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal.
Sci Rep
; 7(1): 7582, 2017 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28790440
7.
Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
PLoS One
; 12(10): e0186244, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023601
8.
Adenoviral L4 33K forms ring-like oligomers and stimulates ATPase activity of IVa2: implications in viral genome packaging.
Front Microbiol
; 6: 318, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25954255
9.
Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time.
Virus Res
; 178(2): 398-403, 2013 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24051000
10.
Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.
PLoS One
; 8(4): e62496, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23638099
11.
Adenoviral vector expressing murine ß-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice.
Virus Res
; 177(1): 55-61, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23892144
12.
Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer.
Virus Res
; 163(1): 202-11, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21971215
13.
Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
PLoS One
; 7(3): e33428, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22432020
14.
Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.
Virus Res
; 161(2): 181-7, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21864589
15.
Production of adenovirus vectors and their use as a delivery system for influenza vaccines.
Expert Opin Biol Ther
; 10(10): 1469-87, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20822477